The US Medicare agency’s implementation plan for the recently enacted price negotiation authority suggests that applying the legislative exemption for “small biotech” companies may be a particularly complicated part of the process.
The Centers for Medicare & Medicaid Services released a timeline for providing guidance on key elements on the Inflation Reduction...







